Triple-negative breast cancer (TNBC) is a breast cancer subtype defined by the absence of progesterone receptor (PR), estrogen receptor (ER), and human epidermal growth factor receptor 2 (HER2) (Won & Spruck, 2020). Here, ESR1 is linked to triple-negative breast carcinoma.